abrdn Healthcare Investors 

Tekla Healthcare Investors is a closed-end investment fund, which engages in investing in the healthcare industry including biotechnology, medical devices, and pharmaceuticals. Its objective is to provide long-term capital appreciation through investments in companies in the healthcare industry. The company was founded on October 31, 1986 and is headquartered in Boston, MA.

Gilead Sciences

iShares Nasdaq Biotechnology ETF

Illumina

IQVIA Hlds

Direxion Daily S&P Biotech Bull 3X Shares

Lonza Group AG

Merck

Navistar

Omega Healthcare Investors

Pfizer

Royalty Pharma

abrdn World Healthcare Fund 

Wuxi Biologics Cayman Inc

SPDR S&P Biotech ETF

Health Care Select Sector SPDR Fund

The recent IRA list of 10 drug publications is not expected to have a significant impact on big pharma stocks in the near term. The legal challenges by big pharma companies against the IRA may derail the implementation of the drug pricing reforms. Investors can consider diversified biotech indexes or healthcare-focused ETFs for exposure to the biopharma sector.

Biopharma Bounce-Back: From Policy Pains To Profitable Plains

abrdn Life Sciences Investors 

BOSTON--(BUSINESS WIRE)--Tekla Healthcare Investors (HQH), Tekla Life Sciences Investors (HQL), Tekla Healthcare Opportunities Fund (THQ) and Tekla World Healthcare Fund (THW), (the “Funds”) today announced that their joint first special meetings of shareholders (“Special Meetings”) were adjourned for a second time until September 12, 2023 at 9:00 a.m. EDT due to lack of a quorum on the proposal to approve a new investment advisory agreement with abrdn, Inc. Shareholders as of the June 16, 2023.

Tekla Funds Announce Second Adjournment of Special Meetings and Urge Shareholder Participation to Limit the Need for Further Solicitation Efforts

BOSTON--(BUSINESS WIRE)--On August 15, 2023, Tekla Healthcare Investors declared a distribution of $0.40 per share. The record date for the distribution is August 25, 2023 and the payable date is September 29, 2023. The Fund will trade ex-distribution on August 24, 2023. Under its distribution policy, the Fund intends to make quarterly distributions at a rate of 2% of the Fund's net assets. Therefore, when the net assets of the Fund are down, the distribution per share amount will decrease and.

Tekla Healthcare Investors Declares Distribution

BOSTON--(BUSINESS WIRE)--Tekla Healthcare Investors (HQH), Tekla Life Sciences Investors (HQL), Tekla Healthcare Opportunities Fund (THQ) and Tekla World Healthcare Fund (THW), (the “Funds”) today announced that their joint special meetings of shareholders on August 14, 2023 (“Special Meetings”) were adjourned until August 29, 2023 to provide additional time for the Funds to reach a quorum on the proposal, described in their definitive joint proxy statement dated July 10, 2023 as filed with the.

Tekla Funds Announce Adjournment of Special Meetings

America faces a silver tsunami as baby boomers enter retirement age. Healthcare costs have outpaced inflation over the past decades, and the trend will continue. Invest in this complex sector with expert-driven diversification and +9% yields.

Healthcare Dividends: Investing In The Lifeline Of Aging America

Tekla Healthcare Investors, a closed-end fund, focuses on the biotech subsector of healthcare, leading to potential volatility but also potential for high returns. The fund's deep discount presents an opportunity for investors after a down year for biotech, but a dollar-cost averaging approach could be a better approach due to volatility. HQH's managed distribution plan provides investors with a distribution yield while waiting through biotech cycles, with long-term capital gains making up the bulk of the distribution classification.

HQH: Deep Discount Presents An Opportunity

Charlie Munger, vice chairman of Berkshire Hathaway Inc., brings a wealth of investment wisdom, priceless for those who seek to learn. Everyone has different requirements and priorities; we will mimic, but not mirror, his investing style.

Invest Like Charlie Munger With 4 Criteria

You want exposure to the healthcare sector in your retirement portfolio. HQH fund has a 35-year track of outperforming and returning value to investors.

4 Reasons HQH Is Great For Retirement Portfolios

Antero Midstream Partners

W. P. Carey

There are generally two separate issues with respect to leaving an estate – spouses and everyone else. Spouses should generally plan to generate enough income to sustain the longer-lived spouse – this means that the spouse who passes first must leave an estate.

Leaving Something Behind For Heirs: How Dividends Beat Annuities

Antero Resources

Legendary fund manager John Neff was a fan of big yields. Investment success does not require glamour stocks or bull markets. - John Neff.

Big Opportunity In The Panic: 2 Fat Yields Up To 9%

The HQH fund aims to provide high total returns through investments in the healthcare industry. HQH has a high allocation to risky biotech stocks and private investments. The fund pays a 2% of NAV quarterly distribution. However, HQH has under-earned relative to its distribution in the past 5 years.

HQH: Higher Risk Healthcare CEF

BNY Mellon Municipal Bond Infrastructure Fund, Inc. 

CEFs trend towards a reversion to mean over time. We find two funds trading outside of their normal discount/premium.

Buy The Dip - 2 Dividends At Bargain Prices

AGNC Investment

Many dividend investments remain oversold and are great opportunities. I invest for income and it allows me to control my retirement outlook.

2 Big Fat Dividends I'm Buying Hand Over Fist

Ares Capital

Ares Dynamic Credit Allocation Fund

AllianceBernstein Global High Income Fund Inc

BlackRock Taxable Municipal Bond Trust

BlackRock Science & Technology

Central Securities

Calamos Convertible Opportunities And Income Fund

DNP Select Income Fund Inc

Eaton Vance Enhanced Equity Income Fund II

Energy Transfer LP Unit

Flaherty & Crumrine Preferred Securities Income Fund Inc

Guggenheim Strategic Opportunities Fund

New American High Income Fund

India Fund Inc

Kayne Anderson MLP Investment

Main Street Capital

Barings Corporate Investors

Nuveen Build America Bond Fund

Annaly Capital

Nuveen Municipal High Income Opportunity Fund

PIMCO Dynamic Income Fund

Cohen And Steers Total Return Realty Fund

Cohen & Steers Reit And Preferred Income Fund Inc

Cohen & Steers Quality Income Realty Fund

Presenting our 2022 year-end review of our 8% Income Portfolio. This high-income portfolio earned over $29,000 in distributions (including year-end special distributions) amounting to over 14% yield-on-cost basis.

The 8% Income Portfolio: 2022 Year-End Review

BlackRock Energy and Resources Trust

Cornerstone Strategic Value Fund Inc

Eaton Vance Tax Advantaged Global Dividend Opportunities Fund

PIMCO Corporate & Income Opportunity Fund

Closed-end funds are great income investments thanks to tax laws and tradition. Being required to pay out most of their taxable gains explains a lot about how CEFs act.

How To Use CEFs For A Rich Retirement

Virtus Artificial Intelligence & Technology Opportunities Fund

ARK Innovation ETF

BlackRock Innovation & Growth Trust

Eaton Vance Tax-Managed Buy-Write Opportunities Fund

Eaton Vance Tax-Managed Global Buy-Write Opportunities Fund

Eaton Vance Tax-Advantaged Bond & Opportunity Stategies Fund

Gabelli Dividend & Income Trust

Voya Asia Pacific High Dividend Equity Income Fund

Voya Global Advantage and Premium Opportunity Fund

iShares Russell 1000 Growth ETF

NXG NextGen Infrastructure Income Fund

Pimco Global Stockplus & Income Fund

Invesco QQQ

SPDR S&P 500 ETF Trust

2022 was a year to forget, while most believe 2023 will begin with the same issues that took the equity and bond markets well into bear market territory last year. That is, a hawkish Federal Reserve that doesn't want to let up on strangling inflation into submission while draining market liquidity.

Equity CEFs: Top Picks For 2023

We share data on over 50 big-yield healthcare investments, including individual stocks, REITs, closed-end funds ("CEFs") and bonds. We dive deeper into three specific attractive big-yield opportunities that also have healthy upside potential.

HQH: 50 Big-Yield Healthcare Stocks, These 3 Worth Considering

The iShares Biotechnology ETF (IBB) is down -12.9% year-to-date but the Tekla biotech equity CEFs are down even more despite NAVs that are holding up extremely well. The result is that the Tekla biotech CEFs (HQH) and (HQL) keep dropping to lower-and-lower valuations with HQH now at a -11.6% discount and HQL at a -12.0% discount.

Equity CEFs: What's Going On With Tekla's HQH And HQL?

Virtus AllianzGI Diversified Income & Convertible Fund

Flaherty & Crumrine Preferred Income Fund Inc

For income investors, closed-end funds remain an attractive investment class that covers a variety of asset classes and promises high distributions and reasonable total returns. Closed-end funds are generally characterized by higher volatility and deeper drawdowns than the broad market. For these reasons, they are not suited for everyone.

5 Best CEFs To Buy This Month (November 2022)

EPR Properties

We all too often give up the most valuable thing - our health - for a few more transient dollars. You can achieve more with less when you create proper goals for retirement.

Stop Trading Your Health For Wealth, Buy Income Instead

HQH is able to generate strong and steady yield which is good enough to ignore the price loss suffered by this fund in a market that's bearish overall. HQH is in a better position to hold up to its current price, and as it trades at a good discount to its NAV, chances are high for this fund.

HQH: A Dividend Paymaster That Fails To Register Price Growth

Despite a catastrophic selloff, healthcare fundamentals are strong. Demand for health services is immune to recession pressures.

Healthcare Stocks Hit 'Buy Points', Load Up With Big Yields: HQH And THQ

Tekla Healthcare has a portfolio, consisting of a variety of well-known biotech and pharmaceutical stocks. Tekla Healthcare is currently trading 4% below NAV.

Tekla Healthcare: 10% Yielding CEF Trading Below NAV

We take a look at the building blocks of an income portfolio. Different types of dividends are best for different purposes.

Build An Income Stream With Fixed, Stable, And Variable Dividends

HQH has a strong and steady dividend history, supported by its earnings. HQH's stock has performed poorly over the past 5 years, but over the long run it has generated stable price growth.

News for abrdn Healthcare Investors ETF (HQH)